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ABSTRACT      61 
BACKGROUND & AIMS: Inflammation markers (IM) have been associated with the 62 
development of chronic diseases. This study compares the effects on IM of three exercise 63 
programs combined with a hypocaloric diet. 64 
METHODS: 119 overweight participants (73 women, 46 men) aged 18–50 years were 65 
randomised into four treatment groups: strength training (S; n=30), endurance training (E; 66 
n=30), combined S + E (SE; n=30), and a diet and physical activity recommendations group (D; 67 
n=29). Energy intake, anthropometric variables (AV), training variables (VO2peak, strength 68 
index, dynamometric strength index [DSI]) and plasma IM were recorded at baseline and after 69 
22 weeks of treatment. 70 
RESULTS: 84 participants completed the study. At 22 weeks, all groups showed a significantly 71 
reduced energy intake (P<0.001) and improved AV (P<0.001). VO2peak significantly increased 72 
in all groups (P<0.01). DSI increased in the exercise groups only (P<0.05). Plasma leptin fell 73 
significantly (P<0.001) in the S and E groups, but not significantly in the SE group (P=0.029) 74 
(no significant differences between these groups). Tumour necrosis factor-α (TNF-α), and C-75 
reactive protein (CRP) concentrations decreased in all groups when examined together, but not 76 
when examined separately.  No significant differences were seen in interleukin-6 (IL-6).  77 
CONCLUSIONS: Combining strength or endurance training with a hypocaloric diet improved 78 
AV and reduced plasma leptin concentrations. No differences were seen between groups in 79 
terms of TNF-α, IL-6 or CRP reduction.  80 
 81 
This trial was registered at clinical trials.gov as NCT01116856. http://clinicaltrials.gov/ 82 
 83 
Keywords: overweight, inflammation, strength training, endurance training, combined training. 84 
 85 
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INTRODUCTION 86 
The majority of epidemiological studies indicate excess body weight during midlife, including 87 
overweight, to be associated with an increased risk of death1-3.  For example, people with a BMI 88 
of 25-28.9 have a relative risk of developing cardiovascular disease twice that of people with a 89 
BMI of <214, while those with a BMI of ≥29 are at almost three times the risk.  Further, the 90 
results of the Framingham Heart Study show that being overweight at age 40 reduces life 91 
expectancy by three years5.  Given the increasing prevalence of obesity, finding more efficient 92 
treatments for overweight should be seen as a public health priority. 93 
Low-grade chronic inflammation is one of the key metabolic alterations linked to excessive 94 
energy intake, physical inactivity and adiposity, and the markers of this inflammation - tumour 95 
necrosis factor-α (TNF-α), interleukin-6 (IL-6) and C-reactive protein (CRP) - have all been 96 
associated with the development of atherosclerosis and insulin resistance 6,7. Several studies 97 
have shown that inflammation markers (IM) are reduced following weight loss 8-10. Physical 98 
exercise may therefore be effective in reducing inflammation.  Indeed, data from observational 99 
and intervention studies show that greater physical activity is associated with lower plasma IM 100 
concentrations 10-13, and regular exercise and an appropriate diet are reported to protect against 101 
all-cause mortality.  This is achieved primarily through protection against atherosclerosis, type 2 102 
diabetes, colon cancer and breast cancer 14-16. 103 
The mechanism that underlies the anti-inflammatory response associated with acute exercise 104 
might, surprisingly, involve an increase in the circulating concentration of IL-6. Under exercise 105 
conditions, this cytokine appears to induce an anti-inflammatory environment by promoting the 106 
production of IL-1ra and IL-10, and by inhibiting TNF-α production 14-16.  Exercise also 107 
increases the release of epinephrine, cortisol, growth hormone, prolactin and other factors that 108 
have immunomodulatory effects 16.  109 
A few studies have tried to determine the types of exercise intervention that produce the greatest 110 
changes in IM concentrations 13,17-20, but the results have been controversial.  A recent review 111 
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indicates that increasing aerobic physical activity may be effective for reducing chronic 112 
inflammation especially in individuals with chronic diseases associated with a state of elevated 113 
inflammation. (Beavers et al., 2010). The aim of the present study was to compare the effects on 114 
plasma IM concentrations of three different exercise programs - strength, endurance, and 115 
combined strength + endurance training - all in conjunction with a hypocaloric diet, and the 116 
normal clinical practice of achieving weight loss using the same hypocaloric diet as above, plus 117 
the provision of recommendations regarding physical activity. 118 
 119 
MATERIALS AND METHODS  120 
 121 
Study subjects 122 
This study was performed as part of the larger study Nutrition and Physical Activity for Obesity 123 
(the PRONAF study according to its Spanish initials), the aim of which was to assess the 124 
usefulness of different types of physical activity and nutrition programs for the treatment of 125 
obesity. Participants were sought via advertisements posted in newspapers and announced on 126 
the radio, the internet and TV. The eligible sample population consisted of 119 overweight 127 
subjects (73 women and 46 men; age range 18–50 years; body mass index [BMI] ≥25–<30 128 
kg/m2) living in the Region of Madrid, Spain.  Eighty four participants completed the study (50 129 
women and 34 men) (Figure 1).  All subjects were healthy adults with no history of relevant 130 
concomitant illness, such as heart, lung or liver disease, or neoplasia. All were normoglycaemic 131 
non-smokers and took no medications or drugs, but led sedentary lifestyles.  All female subjects 132 
had regular menstrual cycles.  The exclusion criteria covered all physical and psychological 133 
diseases that may have precluded the performance of the requested strength or endurance 134 
training, along with the taking of any medication known to influence physical performance or 135 
that might interfere with the interpretation of the results. Subjects with a background of 136 
systematic strength or endurance training (moderate to high intensity training more than once a 137 
week) in the year before the study started were also excluded. In agreement with the guidelines 138 
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of the Declaration of Helsinki regarding research on human subjects, all participants signed an 139 
institutionally approved document of informed consent. All subjects were carefully informed 140 
about the possible risks and benefits of the study, which was approved by the Human Research 141 
Review Committee of the La Paz University Hospital (PI-643).  142 
Study design 143 
Subjects who fulfilled the inclusion criteria and passed a baseline physical examination were 144 
stratified by age and sex and assigned (using a randomisation table) to a strength training group 145 
(S), endurance training group (E), combined strength + endurance training group (SE), or diet 146 
and physical activity recommendations group (D). 147 
This study design was that of an intervention trial of 22 weeks duration. Baseline measurements 148 
for all subjects were made before starting the intervention period.  The final measurements were 149 
taken once the intervention period was over (within 48-72 h of the last training session for the 150 
exercise groups). 151 
Exercise training programs   152 
The different exercise groups followed their corresponding training programs, which in all cases 153 
involved training 3 times/week for 22 weeks. All training sessions were carefully supervised by 154 
certified personal trainers.  An adherence to training of 90% was demanded.   155 
The S group followed a circuit involving the following eight exercises: shoulder press, squat, 156 
barbell row, lateral split, bench press, front split, biceps curl, and French press for triceps.  E 157 
group training involved the use of an exercise bike or cross trainer. The SE group performed a 158 
combination of cycle ergometry, treadmill or cross trainer work, plus weight training with the 159 
following exercises intercalated between lift sets (15 lifts per set): squat, rowing machine, bench 160 
press and front split.  The D group subjects followed the hospital’s habitual clinical practice for 161 
achieving weight loss, i.e., the same dietary intervention as the training groups plus being made 162 
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aware of the general recommendations of the American College of Sports Medicine (ACSM) 163 
regarding physical activity 22.   164 
All subjects were instructed to keep their daily physical activity habits unchanged. These habits 165 
were carefully checked with a dairy registry by personal trainers in all training sessions to the 166 
groups S, E and SE. Group D subjects were not supervised, although they were subjected to 167 
activity monitoring using an armband accelerometer, just as they would be in normal practice. 168 
The exercise programs were designed taking into account each subject’s muscular strength (MS) 169 
and heart rate reserve (HRR). MS was measured in the strength program subjects (S, SE)  170 
using the 15-repetition maximum (15 RM) testing method 21  every other day during the week 171 
before the intervention period. The intraclass correlation coefficient of reliability for all 172 
exercises was ICCr=0.995 for the men and ICCr=0.994 for the women (groups S and SE 173 
subjects together). The HRR was calculated to set the exercise intensity ([maximum heart rate-174 
resting heart rate] x 50% to 60%) and resting heart rate for the E and SE programs.  175 
The intensity of exercise was increased over the study period.  In weeks 2-5, exercise was at an 176 
intensity of 50% of the 15RM and HRR, and lasted an overall 51 min and 15 s (twice around the 177 
circuit, lasting 7 min 45 s each lap).  In weeks 6-14, exercise was performed at an intensity of 178 
60% of 15RM and HRR, again with a duration of 51 min and 15 s (again, twice around the 179 
circuit).  Finally, in weeks 15-23, exercise was performed at an intensity of 60% of 15RM and 180 
HRR, with a duration of 64 min (three times around the circuit).  The recovery period between 181 
circuits was set at 5 min. Participants performed 15 repetitions (45 s) of each exercise with a rest 182 
period of 15 s between them.  Each training session for the S, E and SE subjects commenced 183 
with a 5 min aerobic warm-up, followed by the main session exercises, and concluded with 5 184 
min of cooling down and stretching exercises. In all sessions the exercise rhythm was controlled 185 
by instructions recorded on a compact disk. The cadence for the resistance exercises was fixed 186 
at 1:2 (concentric-eccentric phase).  187 
Hypocaloric diet program 188 
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Hypocaloric diets (between 5028 and 12570 KJ) were prescribed individually for all 189 
participants by expert dieticians at the Department of Nutrition, La Paz University Hospital, 190 
Madrid.  The diet was designed to provide 25% less energy than the baseline daily energy 191 
expenditure (DEE), as measured using a SenseWear Pro Armband™ (Body Media, USA).  192 
Some 29–34% of energy came from fat, 12–18% from protein, and 50–55% from 193 
carbohydrates, according to the recommendations of the Spanish Society of Community 194 
Nutrition (SENC, according to its Spanish initials) 23. The hypocaloric diet program was 195 
followed during the 22-week interventional period. Dietary counselling was given at baseline 196 
and at 12 weeks to resolve questions and to motivate participants sufficiently to comply with 197 
dietary advice. All subjects were instructed on how to record their dietary intake using a daily 198 
log, and given recommended portion sizes and information on possible food swaps. In addition, 199 
voluntary group nutrition education sessions were given by the dieticians. The goal was to equip 200 
the participants with the knowledge and skills necessary to achieve gradual but permanent 201 
behavioural changes. 202 
 203 
Analytical methods, measurement of training variables, dietetic study, and anthropometric 204 
variables  205 
The following analyses and measurements were made at baseline and at the end of the study 206 
period. 207 
- Blood analysis: Blood samples were taken early in the morning at the La Paz University 208 
Hospital Extraction Unit after a 12 h overnight fast. Samples were kept at 4-6ºC until analysis, 209 
which was always performed within 48 h. Plasma C-reactive protein concentrations (CRP) were 210 
determined using a BNII nephelometer (Siemens Healthcare Diagnostics GmbH, Eschborn, 211 
Germany). Plasma leptin, IL-6 and TNF-α concentrations were determined using a Luminex®-212 
LX200 Analyzer (Millipore Corp, Billerica, Massachusetts, USA) and a MILLIPLEX MAP 213 
human circulating cancer biomarker magnetic bead panel (HCCBP1MAG-58K) (Millipore, St. 214 
Charles, Missouri, USA).  All samples were analysed in duplicate.  Data were analysed using 215 
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xPONENT v.3.1 software (Millipore). The intra- and interassay coefficients of variation for the 216 
cytokine assays all fell in the 5-10% range. 217 
- Training variables: Peak oxygen uptake (VO2peak) was measured using the protocol described 218 
by Bruce24. The test was conducted on an H/P/COSMOS 3P 4.0 computerised treadmill 219 
(H/P/Cosmos Sports & Medical, Nussdorf-Traunstein, Germany). The volume and composition 220 
of expired gas were measured using a Jaeger Oxycon Pro gas analyser (Erich Jaeger, Viasys 221 
Healthcare, Germany)  The general strength index (SI) was calculated following the method of 222 
Jurca et al. (2004)25. This method measures the strength of the leg and arm with respect to body 223 
weight via two exercises: the bench press and squat. The dynamometric strength index (DSI) 224 
was determined by measuring muscular strength using a Tecsymp Tkk5002 hand and leg 225 
dynamometer (Tecsymp, Barcelona, Spain) and a Tecsymp Tkk5401 back dynamometer 226 
(Tecsymp, Barcelona, Spain).  The DSI value was calculated as the sum of the values obtained 227 
with both apparatuses divided by subject body weight. 228 
- Dietetic study: All food and beverages consumed by the participants were recorded using a 229 
food frequency questionnaire and a “3-day food and drink record”, validated for the Spanish 230 
population 26, at the beginning and end of the intervention. Participants were instructed to record 231 
the weights of food consumed whenever possible, and to use household measurements 232 
(tablespoons, cups, etc.) when not. The energy and nutritional content of the foods consumed 233 
were then calculated using DIAL software (Alce Ingeniería, 2004). The Healthy Eating Index 234 
(HEI) was calculated according to Kennedy et al., 27 taking into account the number of servings 235 
recommended for the Spanish population28. Compliance with recommended intakes was 236 
assessed for the different food groups (cereals, vegetables/greens, fruits, dairy products, meat/ 237 
fish/eggs, expressed in servings per day), and also from the point of view of meeting nutritional 238 
objectives (intake of lipids, saturated fatty acid, cholesterol and sodium, and dietary variety). 239 
Each of these 10 factors was awarded a maximum of 10 points when the intake was the same as 240 
that recommended, and a minimum of 0 points when the difference was very great. Intermediate 241 
values were awarded proportionally 27. Diet quality was deemed "'good" when more than 80 242 
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total points were scored, as "needing improvement" when the score was 51-80, and "poor" when 243 
below 51 27. 244 
- Anthropometric variables (AV):  Height was measured using a SECA stadiometer (range 80-245 
200 cm).  Body weight was measured using a TANITA BC-420MA balance (Bio Lógica 246 
Tecnología Médica S.L, Barcelona, Spain).  The BMI was calculated as [body weight 247 
(kg)/(height (m))2]. The waist circumference (WC) was measured using a Seca 201 steel tape 248 
(Quirumed, Valencia, Spain). Dual-energy x-ray absorptiometry (DXA) was used to measure 249 
the percentage total fat mass (TFM%), percentage android fat (AF%), the android/gynoid fat 250 
ratio (AF/GF), and the lean mass (kg), employing a GE Lunar Prodigy apparatus (GE 251 
Healthcare, Madison, Wisconsin, USA).  All DXA scans were performed making use of GE 252 
Encore 2002 software v. 6.10.029. 253 
Percentage changes from baseline were calculated for the studied variables as: (final value - 254 
baseline value/ baseline value) X 100.  255 
 256 
Statistical analysis 257 
Means and standard deviations (SD) were calculated for normally distributed continuous 258 
variables, and medians and interquartile ranges (IQR) for non-normally distributed continuous 259 
variables. The Kolmogorov-Smirnov test was used to determine whether or not the data were 260 
normally distributed among groups. For variables that were not normally distributed, differences 261 
between the four groups at baseline and after the intervention were compared using the Kruskal-262 
Wallis test. Adopting a closed testing procedure, post hoc pairwise comparisons were performed 263 
using the Mann-Whitney test if the results of the Kruskal-Wallis test showed significant 264 
differences. For the variables that were normally distributed, differences between groups were 265 
compared by one way ANOVA plus Bonferroni’s post hoc adjustment. The change within each 266 
group was determined using the Wilcoxon test or paired Student t test depending on the data 267 
distribution. Significance was generally set at P<0.05; however, Bonferroni adjustments were 268 
used to take into account multiple comparisons. Thus, the P values for intergroup comparisons 269 
were considered significant when P<0.0083 (0.05 divided by six possible comparisons for each 270 
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variable) and P<0.0125 for within-group comparisons (0.05 divided by four possible within-271 
group changes). 272 
Linear and multiple regression analyses were performed to determine the potential role of 273 
changes in AV, energy intake and training variables as predictors of change in IM.  Dummy 274 
variables were used to represent the S, SE and E groups in the multiple regression analysis.  275 
The sample size of the PRONAF study was calculated to detect any effect of training and diet 276 
on TFM% (with 80% statistical power, with significance set at P<0.05, assuming a correlation 277 
of 0.80 between repeated measures, 29 and assuming an estimated drop out of 20%); it was not 278 
explicitly determined to analyse the influence on IM.  279 
All analyses were performed using SPSS v.17.0 software (SPSS Inc., Chicago, IL, USA). 280 
 281 
RESULTS 282 
All groups showed similar baseline characteristics except for the leptin concentration which 283 
differed between the S and SE group, the IL-6 concentration which differed between the S and 284 
E subjects, and between the E group and SE group, the CRP concentration which differed 285 
between the E and SE groups, and the BMI which differed between the S and SE groups 286 
(P=0.011) (Table 1).  287 
Tables 1 and Table 2 show, by group, the changes in body composition and inflammatory and 288 
training variable values after the intervention. Significant reductions were seen in the BMI, WC, 289 
TFM and AF in all groups. Lean mass did not change in any of the exercise groups but showed 290 
a trend towards a significant reduction in group D (P=0.029). The change in TFM% from 291 
baseline was -11.6%, -11.5%, -19.4% and -9.7% in the S, E, SE and D group respectively. 292 
VO2peak significantly increased in all groups. DSI increased in the three exercise groups, but not 293 
in group D. The SI increased in the S and SE groups, the increase in the latter being 294 
significantly greater (P<0.01) (Table 1).  295 
Good compliance with the diets was achieved over the 22-week diet intervention period (Table 296 
3). All groups significantly reduced their energy intake: S group -2530±2497, E group -297 
2266±1495, SE group -2057±2459, D group: -2497±2040 KJ (P<0.001), with no significant 298 
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differences between groups. At baseline, all groups had a diet "needing improvement” and at the 299 
end all had a significantly improved HEI index, the diet quality now being “good” (S: 66.8±12.7 300 
to 81.14±8.9, P<0.001; E: 68.8±87.1 to 87.1±4.9, P<0.01; SE: 62.72±11.30 to 83.5±8.0, 301 
P<0.001; D: 62.8±10.8 to 83.2±11.3, P<0.001).  302 
The reduction in the plasma leptin concentration was significant in the S and E groups 303 
and tended towards significance in the SE group (P=0.016); no change was seen in the 304 
D group (Table 2).  The percentage change in leptin after the intervention was -27.2%, -305 
37.5%, -32.6% and -2.5% for the S, E, SE and D groups respectively. A significant 306 
difference in the change in leptin concentration was observed between the S and D 307 
groups (-6.70±1.89 vs. -0.86±1.78 pg/mL, p=0.011) and between the E and D groups (-308 
3.33±2.17 vs. -0.86±1.78 pg/mL, p=0.016) after the intervention. No significant 309 
difference in plasma leptin changes were seen among the three exercise groups (Table 310 
2). 311 
When taking the subjects of all four groups together, the plasma TNF-α  and CRP 312 
concentrations decreased between baseline and the end of the intervention (4.48±2.06 313 
vs. 4.18±1.94 pg/ml, P<0.05; and 3.19±3.94 vs. 2.85±4.44 mg/dl, P<0.05 respectively).  314 
No significant changes were seen, however, in plasma IL-6. 315 
Linear regression analysis was used to determine the extent to which improvements in the AV, 316 
training variables and energy intake may have contributed to the changes in IM (Table 4). 317 
Changes in CPR were not significantly associated with any other variable.  Changes in the 318 
leptin concentration were significantly associated with several variables.  Multiple regression 319 
analysis was therefore performed to identify those with the greatest influence on this change. 320 
The model included five variables: change in TFM% baseline leptin concentration and training 321 
group (S, E or SE). BMI was the anthropometric variable with the greatest coefficient of 322 
determination (R2=0.177), but change in TFM% was included in analyses since BMI is not a 323 
measure of body composition or fat distribution. Baseline leptin concentrations were included in 324 
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the model due to the baseline intergroup differences observed.  The results showed that the 325 
change in TFM% (β=0.492; P=0.0001) plus the difference in baseline leptin concentration (β=-326 
0.464; P=0.0001) explained 38.3% of the change in leptin concentrations (R2=0.383, 327 
P=0.0001). The type of exercise regimen, however, had no influence on this change (S group, 328 
β=-0.172, P=0.159; E group, β=-0.209, P=0.077; SE group, β=-0.030, P=0.802). 329 
 330 
DISCUSSION  331 
The combination of the different exercise modalities plus a hypocaloric diet produced slight 332 
improvement in subjects’ IM values. Groups whose regimen involved following an exercise 333 
program showed greater reductions in leptin concentrations, with no differences seen among 334 
these groups. Moreover, CRP levels tended towards a significant reduction with the E program.    335 
Overweight individuals commonly have high plasma IM concentrations 30. Indeed, the baseline 336 
IM values recorded in the present study were higher than those observed in the normal weight 337 
population by other authors 31, and similar to or higher than the values observed in the 338 
overweight population 32-34.  The most recent literature suggests that adipose tissue macrophage 339 
density increases with weight gain, reducing the production of anti-inflammatory adipokines 340 
and increasing the secretion of pro-inflammatory cytokines 35. This chronic inflammatory 341 
situation contributes to the development of atherosclerosis, insulin resistance, tumour growth 342 
and neurodegeneration 3,14,35-38.  Knowledge of therapeutic strategies that might reduce 343 
inflammation are therefore important when deciding on the treatment of overweight/obesity and 344 
the prevention of its associated complications.  Several studies have documented that weight 345 
loss in conjunction with energy restriction can improve IM concentrations 8-10. However, the 346 
effect of exercise on IM is controversial and not well documented 13,17-20.  347 
During exercise, IL-6 is produced by muscle fibres. IL-6 is normally associated with low grade 348 
inflammation, but under conditions of physical exercise it appears to stimulate the appearance in 349 
the blood of anti-inflammatory cytokines such as interleukin-1 receptor antagonist (IL-1ra) and 350 
IL-10, and to inhibit the production of proinflammatory cytokine TNF-α 14,16. Typically, IL-6 is 351 
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the first cytokine present in the circulation during exercise, the concentration attained related to 352 
the intensity and duration of exercise, the muscular mass, and the subject’s endurance capacity 353 
14,16,36
.  It declines in the post-exercise period.  In the present work, no significant changes were 354 
observed in IL-6 between the beginning and end of the intervention period.  It may be that more 355 
than 22 weeks are necessary for any change to be noticed, as suggested by Libardi et al. (2011) 356 
39
. In other studies, times of 10 12 or even 12 months 17 have been required.  However, some 357 
studies with long intervention periods (1 year 32,40, 18 months 41) report no alterations in IM.   358 
Short-term (12-week) low to moderate intensity aerobic exercise has been reported not 359 
to change IL-6, TNF-α or CRP levels in obese women 42. However, longer-term (7-360 
month) training at higher intensity and frequency has been indicated to reduce body 361 
weight, body fat, CRP and TNF-α, and to increase adiponectin levels in obese young 362 
women 43. In the present study, increasing the intensity and frequency of training intervention 363 
beyond the levels set was rejected due to the previous sedentary lifestyles of the subjects, and 364 
because of the increased the risk of injuries and dropout that this might entail.                                    365 
No association was seen between changes in IL-6 (which were not significant) and that of any 366 
other variable, except for TNF-α: as IL-6 increased, so did TNF-α.   (Table 3). The literature 367 
suggests, however, that IL-6 produced during exercise exerts an inhibitory effect on TNF-α. 368 
Concentrations of TNF-α are markedly elevated in anti-IL-6-treated mice and in IL-6-deficient 369 
knockout mice14.  Further work is needed to determine the cause of this discrepancy. 370 
At the end of the 22-week intervention period, no differences were seen between the different 371 
exercise groups in terms of TNF-α reduction. This may have been a consequence of the small 372 
sample size; more subjects may be required in each group for differences to be detected.  373 
However, other authors who have compared different exercise types have found no 374 
differences either 7,12. Nonetheless, some studies employing similar methodology but 375 
using patients with diabetes, and of a wider age range, have reported just the opposite.  376 
For example, Balducci et al. (2010) observed a significant reduction in a group 377 
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subjected to a combination of supervised aerobic exercise and resistance training 17.  In 378 
contrast, in a smaller number of hospitalised patients with diabetes following a strict 379 
hypocaloric diet for 21 days, Lucotti et al. (2011) observed that while the members of a 380 
group assigned to endurance training experienced significant reductions (some 20%) in 381 
TNF-α, those assigned to combined strength + endurance training experienced an increase in 382 
this IM.  383 
No association was found between the changes in TNF-α and any AV or training 384 
variable.  The reduction in energy intake and the changes in IL-6 concentration (though 385 
not significant in themselves) were the only variables independently associated with 386 
changes in the TNF-α concentration. 387 
No significant reduction in CRP levels was seen for any group.  The great dispersion of 388 
the results may explain this.  Other authors have reported conflicting information.  For 389 
example, Jorge et al. (2011) reported reductions in subjects following strength, 390 
endurance, and strength + endurance programs 13. Donges et al. (2010) and Kohut et al. 391 
(2006)  reported reductions only in those groups undertaking endurance exercise 18,12, 392 
and Balducci et al. (2010) reported reductions only in groups assigned to combined 393 
strength + endurance training 17.  Both the dispersion observed in the present work, and 394 
the discrepancies in the results of other authors, might be due to the nonspecific nature 395 
of CRP as an IM 13. Being an acute phase reactant, its circulating concentrations 396 
increase rapidly whenever a situation of inflammation, infection or immune dysfunction 397 
develops 44. In fact, in the present work, no association was found between changes in 398 
CRP and any other variable.  399 
Leptin is synthesized and secreted primarily by adipocytes, and the amount in plasma is 400 
proportional to that present in the adipose tissue. Its main role is to provide the central 401 
nervous system a signal of energy intake and of the energy stores in the body, thus 402 
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allowing the hypothalamus to keep the body weight stable 45,46.  After an energy-403 
restricted diet, leptin concentrations fall in proportion with the amount of fat lost 47,48. In 404 
the present work, leptin concentrations showed a significant decline in the S and E 405 
groups.  Despite showing the greatest reductions in BMI and TFM%, the SE group 406 
showed no significant reduction in leptin (although it tended towards a significant 407 
reduction).  It should be remembered that this group started with a considerably more 408 
favourable baseline leptin concentration; in fact it was significantly lower than that of 409 
the S group, which may have limited the identification of possible differences.  The 410 
latter finding disagrees with that reported by other authors 47,48. However, it agrees with 411 
that reported by Kondo et al. (2010) who examined eight obese subjects who performed 412 
strength exercises more than 30 min four to five times week for seven months, and in 413 
whom a significant reduction in circulating leptin of 25% was observed 47. In the 414 
present study, the percentage reduction in leptin was higher in all exercise groups than 415 
in the D group (S group: 27.2%, E group: 37.5%, SE group: 32.6%). Fisher et al. (2010) 416 
and Lucotti et al. (2011) reported significantly reduced leptin levels in endurance 417 
training groups, while those of subjects who had undergone combined strength + 418 
endurance training experienced no such change 7,19. In a study of longer duration, 419 
Balducci et al. (2010) reported that groups that undertook supervised endurance and 420 
combined endurance + strength exercises experienced significant reductions in leptin of 421 
27% and 47% respectively. The discrepancies between the present results and those of 422 
the above authors may be associated with differences in the change in TFM%, the 423 
length of the intervention, the presence/absence of a dietary intervention, or the training 424 
methodology employed in each 17.   425 
Finally, since improvements in AV, energy intake and training variables were seen, 426 
linear regression analysis was performed to identify the main variables associated with 427 
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changes in the serum leptin concentration.  Changes in BMI, TFM%, AF%, undertaking 428 
a supervised exercise program (S, E or SE) and gender (see Table 3) were all found to 429 
be independent predictors of changes in the leptin level. Multiple regression attributed 430 
38.3% of the change in leptin concentration to variation in the percentage of TFM%, 431 
plus the undertaking of supervised exercise, plus the baseline leptin concentration.  432 
However, within this model, neither undertaking such exercise nor the type of exercise 433 
undertaken (S, E or SE) had a significant effect on leptin concentration, accounting for 434 
just 5.9% and 4.4% of this change respectively. These results highlight the great interest 435 
in identifying other independent variables (e.g., other IM, visceral fat mass, cortisol and 436 
growth hormone concentrations, as well as other dietary variables not investigated in the 437 
present work) that might be associated with this change. 438 
A point of interest of the present study is that it is the first to include normoglycaemic, 439 
young to middle-aged men and women.  Other studies that have included different types 440 
of exercise have only looked at women, the elderly, and patients with diabetes.  A 441 
limitation of the present study was the reduced number of subjects in each exercise 442 
group, a consequence of a larger number of withdrawals than anticipated. The sample 443 
size of the PRONAF study was selected to detect an effect of training and diet on 444 
TFM%, but, unfortunately, not to detect an effect on IM. This prevented determining 445 
which of the three exercise regimens had the greatest effect on serum IM 446 
concentrations. The results of the present study could, however, assist researchers in the 447 
calculation of appropriate sample sizes for future clinical trials focused on clarifying the 448 
effect of exercise and hypocaloric diet programs on IM. 449 
The present study is of interest since the state of chronic inflammation that accompanies 450 
overweight and obesity, manifested as high concentrations of non-muscle-produced IL-451 
6, TNF-α and CRP, contributes towards the development of atherosclerosis, insulin 452 
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resistance and other chronic diseases.  A reduction in the concentrations of these 453 
markers might help prevent the appearance of these complications.   454 
In conclusion, the present results show that strategies combining supervised physical 455 
exercise and a hypocaloric diet can provide benefits in terms of body composition and 456 
slight improvements in IM, especially in leptin, with no differences among the physical 457 
exercise program.  Further studies with larger sample sizes are required to clarify the 458 
specific influence of different exercise types on IM concentrations. 459 
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Figure 1: Participation flow diagram for the PRONAF study. Recruitment methods 624 
included all types of media advertisement. A total of 1568 candidates were screened, of 625 
whom 119 were randomised into the PRONAF study. The dropout rates in the groups 626 
were: endurance group (E) 16.6 %, strength group (S) 26.6 %, combined group (SE) 627 
23.3%, and diet and physical activity recommendations group (D) 31.03 %. 628 
 629 
 630 
 631 
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Table 1. Anthropometric and training variables in each treatment group before and after the intervention (expressed as mean values ± (SD)). 
 
S  n=19 E  n=25 SE n=22 D n=18 
 Baseline Final Baseline Final Baseline Final Baseline Final 
Gender (male/female) 7/12  10/15  10/12  7/11  
Age (years) 36.46(8.9)  35.69 (8.07)  36.71 (6.99)  36.77 (9.24)  
BMI (kg/m2) 29.51 (2.00) a2º 27.43 (2.08) 
†*** 
28.91 (1.78) 26.41 (2.04) 
†*** 
28.32 (1.54) 25.36 (1.84) 
†*** 
28.502 (1.29) 26.19 (1.91) †*** 
WC (cm) 97.03(6.54)  88.72 (7.94) 
†*** 
95.76(8.32) 88.05 (8.04) 
†*** 
95.51(7.23) 85.39 (6.545) 
†***b6** 
95.13 (6.08) 86.47(6.59) †*** 
TFM (%)  40.27 (6.76)  36.10 (7.77) 
†*** b3º 
39.89 (5.63) 35.32 (6.80) 
†***b4º 
37.05 (6.00) 30.04 (7.68) 
†***b6** 
40.20 (5.90) 36.63 (3.26) †*** 
AF (%) 46.30 (6.57) 40.77 (8.59) 
†***b2º 
44.82 (7.19) 38.19 (9.37) 
†*** 
43.11 (5.58)  32.56 (8.77) 
†***b6º 
45.48 (7.41) 39.99 (7.83) †*** 
A/G (%) 1.10 (0.17) 1.06 (0.16) 1.07 (0.16) 1.02 (0.19) †** 1.16 (0.26) 1.07 (0.24) 
†*** 
1.06 (0.19) 1.01 (0.17) †º 
LM (kg)  46.78 (10.29) 46.82 (11.10) 
b3º
 
46.04 (8.71) 45.60 (8.61) 48.40 (9.14) 48.24 
(9.51)b6º 
46.44 (8.21) 45.46 (7.47) †º 
VO2peak (ml/min/kg) 2476 (692) 2742 (921) 
†** 
2473 (622) 2745 (655) 
†*** 
2768 (767) 3134 (888) 
†*** 
2746 (734) 2468 (664) †** 
 SI  0.99 (0.32) 1.20 (0.52) 
†**b2** 
- - 1.14 (0.25) 1.59 (0.39) 
†*** 
- - 
DSI  3.20 (0.86) 3.73 (1.32) 
†*b3** 
3.36 (0.81) 3.72 (0.84) †* 3.74 (0.74) 4.25 (0.69) 
†*** 
3.27 (0.54) 3.55 (0.71) 
S = Strength group; E = Endurance group; SE = Combined strength and endurance group; D = Diet and physical activity recommendations group. WC: waist 
circumference; TFM: Total Fat Mass; AF: Android Fat; A/G: Android/Gynoid ratio; LM: Lean mass.  
VO2peak: Peak oxygen uptake; SI: Strength Index; DSI: Dynamometric Strength Index. 
a
 Intergroup baseline differences (a1 S-E; a2 S-SE; a3 S-C; a4 E-SE) ;  b Intergroup final differences (b1 S-E; b2 S-SE; b3 S-C; b4 E-SE; b5 E-C; b6 SE-C); † Intragroup 
differences after 22 weeks of intervention. Significance of differences:  º Trend towards significance: P<0.029; * P<0.05; ** P<0.01; *** P<0.001 
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Table 2. Inflammatory marker concentrations in each treatment group before and after the intervention (expressed as median (IQR)). 
 
S  n=19 E  n=25 SE n=22 D n=18 
 Baseline End Baseline End Baseline End Baseline End 
TNF α (pg/ml) 4.96 (4.18-5.48) 4.44 (3.98-5.21) 3.60 (3.14-
4.87) 
3.31 (2.66-
4.38) 
4.68 (0.91-7.33) 4.41 (0.73-
6.17) 
4.51 (4.15-4.99) 4.47 (4.14-4.96) 
Leptina (ng/ml) 27.78 (8.87-39.17) 
a2** 
 
17.65 (7.48-
32.28) †*** b3ºb5º 
21.20 (5.81-
36.64) 
5.81 (3.95-
23.62) †*** 
5.07  (3.34-
18.44)  
3.67(1.64-
11.30) †º 
16.46 (8.96-
26.16) 
13.86 (7.05-26.49) 
CRP (mg/dl) 1.89 (0.69-3.62) 1.45 (0.79-3.17) 2.09  (1.00-
5.07) a4** 
1.02 (0.79-
4.05) †º 
0.96  (0.79-
2.08) 
0.79 (0.79-
2.01) 
2.45 (1.14-5.61) 1.28 (0.79-4.12) 
IL-6 (pg/ml) 2.60 (2.28-3.75) 
a1**
 
2.70 (1.97-4.90) 4.89 (3.42-
7.89) a4*** 
4.44 (3.32-
5.34) 
2.45 (0.13-3.65) 
2.45 (0.13-3.65)  
2.11 (0.11-
3.67) 
2.29 (1.80-2.83) 2.02 (1.78-2.3) 
S group = Strength group; E group = Endurance group; SE group = Combined strength + endurance group; D group = Diet and physical activity 
recommendations group. 
IQR: interquartile range; TNF α: Tumor necrosis factor; IL-6: Interleukin 6; CRP: C-reactive protein. 
a
 Intergroup baseline differences (a1 S-E; a2 S-SE; a3 S-C; a4 E-SE) ;  b Intergroup final differences (b1 S-E; b2 S-SE; b3 S-C; b4 E-SE; b5 E-C; b6 SE-C); † Intragroup 
differences after 22 weeks of intervention. Significance of differences:  º Trend towards significance: P<0.029; * P<0.05; ** P<0.01; *** P<0.001 
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Table 4. Dietetic parameters in each treatment group before and after the intervention (expressed as means ± (SD)). 
 
S n=22 E n=25 SE n=23 D n=19 
 Before After  Before After  Before After  Before After  
Carbohydrates (%) 40.53 (7.20) 49.13 (7.27) 
†***
 
37.57 (5.03) 49.97 (7.17) 
†***
 
37.99 (6.98) 46.25 (3.93) 
†***
 
36.45 (8.06) 44.43 (4.84) †*** 
Proteins (%) 
 
20.49 (4.12) 18.40 (2.36)  20.51(3.58) 18.94 (2.91)  20.51 (3.84) 18.51 (2.17)  22.18 (9.75) 19.74 (3.09)  
Fat (%) 38.24 (6.11) 32.45 (6.17) 
†**
 
41.92 (4.87) 31.08 (0.81) †** 41.49 (6.75) 35.22 (3.56) 
†***
 
41.35 (6.69) 35.81 (5.24) †*** 
SAF (%) 12.10 (2.66) 9.76 (2.42) 13.61 (2.60) 10.14 (3.58) 
†***
 
14.14 (3.11) 9.54 (1.87) †*** 14.03 (3.23) 10.19 (2.39) †*** 
HEI 66.78 (12.65) 66.90 (5.37) 68.78 (14.28) 87.14 (4.87) †** 62.72 (11.30) 83.51 (8.02) 
†***
 
62.76 (10.76) 83.24 (11.29) †*** 
S group = Strength group; E group = Endurance group; SE group = Combined strength + endurance group; D group = Diet and physical activity recommendations 
group. SAF: saturated fatty acids. HEI: Healthy Eating Index. 
† Intragroup differences after 22 weeks of intervention. Significance of differences: ** P<0.01; *** P<0.001 
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Table 3. Regression analysis of change in body composition, training variables and energy intake over the treatment period as predictors of 
changes in inflammation markers. 
 
 
Inflammation 
marker 
Variable R2 B 95% confidence 
interval 
Standard β-
coefficient 
P value 
∆ BMI (kg/m2) 0.177 2.60 (0.64) 1.31-3.88 0.420 0.000 
∆ WC (cm) 0.093 0.60 (0.21) 0.17-1.03 0.305 0.007 
∆ TFM (%) 0.092 0.81 (0.29) 0.22-1.39 0.303 0.007 
∆ AF (%) 0.069 0.39 (0.16) 0.06-0.72 0.263 0.021 
Supervised 
exercise program 
(S + E+ SE) 
0.061 -5.45 (2.42) -10.29-(-0.62) -0.247 0.027 
∆ Leptin 
Gender 
(male/female) 
0.127 6.66 (1.97) 2.72-10.60 0.357 0.001 
∆ TNFα ∆ Energy (KJ/day) 0.060 0.001(0.00) 0.00-0.01 0.244 0.045 
∆ IL-6 ∆ TNFα (pg/ml) 0.415 1.00 (0.135) 0.77-1.23 0.644 0.000 
∆= Final value – Baseline value. 
S group = Strength group; E group = Endurance group; SE group = Combined strength + endurance group 
BMI: body mass index; WC: waist circumference; TFM: Total Fat Mass; AF: Android Fat 
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